Welcome to our dedicated page for elf Beauty SEC filings (Ticker: ELF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
e.l.f. Beauty’s rapid product drops and cruelty-free formulas delight consumers—but they also generate dense SEC paperwork that can bury the metrics investors care about. If you have ever tried to trace how a new Keys Soulcare launch affects gross margin or wondered when executives exercise options, you know the challenge.
Stock Titan decodes every e.l.f. Beauty SEC filing the moment it appears on EDGAR. Our AI-powered summaries translate a 300-page annual report into plain-English takeaways—channel mix, ingredient cost trends, and sustainability disclosures—in seconds. Whether you need the e.l.f. Beauty annual report 10-K simplified or an e.l.f. Beauty quarterly earnings report 10-Q filing, the platform offers real-time access plus concise explanations you can act on.
Key documents covered include:
- Form 4 alerts for e.l.f. Beauty insider trading Form 4 transactions—get e.l.f. Beauty Form 4 insider transactions real-time so you can monitor executive stock moves.
- 8-K notifications with e.l.f. Beauty 8-K material events explained, from influencer partnerships to supply-chain updates.
- Proxy materials detailing e.l.f. Beauty proxy statement executive compensation and ESG-linked pay metrics.
Need quick answers? Just type a natural question such as “understanding e.l.f. Beauty SEC documents with AI” or “e.l.f. Beauty earnings report filing analysis” and our engine surfaces the relevant paragraph, table, or footnote. Professional use cases include tracking segment performance across brands, spotting e.l.f. Beauty executive stock transactions Form 4, and comparing quarter-over-quarter marketing spend—all without wading through legal jargon.
From AI-generated highlights to downloadable originals, you’ll find every filing type, every quarter, updated the moment e.l.f. submits it. Save hours, gain clarity, and make informed decisions faster.
e.l.f. Beauty, Inc. filed Amendment No. 1 to its Form 8-K to provide required financial statements and unaudited pro forma information related to its August 5, 2025 acquisition of HRBeauty LLC (“rhode”).
The filing includes rhode’s audited consolidated financial statements as of and for the year ended December 31, 2024 (Ex. 99.1), unaudited condensed financial statements as of and for the six months ended June 30, 2025 (Ex. 99.2), and unaudited pro forma condensed combined statements: a balance sheet as of June 30, 2025 and statements of operations for the year ended March 31, 2025 and the three months ended June 30, 2025 (Ex. 99.3). The pro forma data are presented for illustrative purposes only. The amendment makes no other changes to the original 8-K.
Tarang Amin, who is listed as Chief Executive Officer and a Director of e.l.f. Beauty, Inc. (ELF), reported multiple transactions with an earliest transaction date of 10/01/2025. The filing shows an exercise of 116,315 stock options at a $17 exercise price executed under a 10b5-1 trading plan adopted on June 13, 2025, and subsequent sales of those same 116,315 shares in multiple trades at weighted-average prices reported across four grouped sales. After these transactions the reporting person holds 78,222 shares directly and additional indirect holdings through family trusts and partnerships, including reported indirect blocks of 228,037, 468,532, and two trusts of 40,295 each. The filing also discloses 81,818 restricted stock units included in beneficial ownership.
e.l.f. Beauty, Inc. notice reports a proposed sale of 116,315 common shares on the NYSE through Morgan Stanley Smith Barney, with an aggregate market value of $15,409,411.20 and 56,734,903 shares outstanding. The shares were acquired and paid for on 10/01/2025 by exercise of stock options from the issuer, with cash payment the same day. The filer certifies no undisclosed material adverse information and indicates no sales in the prior three months. This is a routine Form 144 disclosure of an intended sale by a person who recently exercised options.
Kory Marchisotto, Senior Vice President and Chief Marketing Officer of e.l.f. Beauty, Inc. (ELF), reported the sale of 10,812 shares of common stock on 09/17/2025 at a reported price of $150 per share. Following the reported sale, the filing shows beneficial ownership of 133,976 shares, which the filer discloses includes 47,398 restricted stock units. The sale was executed under a 10b5-1 trading plan adopted by the reporting person on 12/10/2024. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/19/2025.
Scott Milsten, a senior executive of e.l.f. Beauty, Inc. (ELF), reported the sale of 15,000 shares of the company’s common stock under a pre-established 10b5-1 trading plan adopted June 11, 2025. The shares were sold on 09/17/2025 in multiple trades at prices ranging from $150.00 to $150.77, with a weighted average sale price of $150.2285. After the sale the reporting person beneficially owned 97,406 shares directly, plus an additional 22,761 shares held indirectly by the Milsten/Conner Trust dated October 17, 2008, which includes 46,855 restricted stock units.
The Form 4 identifies Milsten’s roles as Senior Vice President, General Counsel, Corporate Secretary & Chief People Officer and confirms the transaction was executed pursuant to the specified 10b5-1 plan. No derivative securities were reported.
Insider sale by e.l.f. Beauty CFO reported on Form 4. Mandy J. Fields, Senior Vice President and Chief Financial Officer, reported the sale of 5,298 shares of e.l.f. Beauty, Inc. (ELF) on 09/17/2025 under a pre-established 10b5-1 trading plan adopted June 9, 2025. The reported weighted-average sale price was $150.2073, with executed trade prices ranging from $150.00 to $150.37. Following the sale, Ms. Fields beneficially owns 58,856 shares, which includes 47,398 restricted stock units. The filing was signed by an attorney-in-fact on 09/18/2025.
Joshua Allen Franks, SVP, Operations at e.l.f. Beauty, Inc. (ELF), reported an insider sale on 09/16/2025 carried out under a pre-established 10b5-1 trading plan adopted December 9, 2024. The filing shows 7,913 shares were sold at $145 per share. After the sale Mr. Franks beneficially owned 99,369 shares, which the filing notes include 47,398 restricted stock units. The Form 4 was signed by an attorney-in-fact on 09/18/2025. No derivatives or other transactions are reported in this filing.
Form 144 filing for e.l.f. Beauty, Inc. (ELF): An insider proposes to sell 10,812 common shares through Morgan Stanley Smith Barney on 09/17/2025 with an aggregate market value of $1,549,143.36. The filer reports total shares outstanding of 56,734,903, so the proposed sale represents approximately 0.019% of outstanding shares. The shares were originally acquired as restricted stock units on 03/01/2023. The filing also discloses a recent 10b5-1 sale on 09/12/2025 of 13,515 shares for gross proceeds of $1,893,477.37.
Form 144 notice for e.l.f. Beauty, Inc. (ELF) shows a proposed sale of 5,298 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $759,097.44. The shares approximate 56,734,903 shares outstanding and are scheduled for sale on or about 09/17/2025 on the NYSE. The securities were acquired as Performance Stock Units from the issuer on 04/21/2025 and fully vested/paid on that date. The filing also discloses 10b5-1 sales by Mandy Fields of 55,692 shares on 09/08/2025 generating $7,589,682.39. The filer affirms no undisclosed material adverse information and references Rule 10b5-1 procedures.
Insider sale notice for e.l.f. Beauty, Inc. (ELF): This Form 144 reports a proposed sale of 15,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $2,149,200, scheduled approximately on 09/17/2025. The filer, identified in related sale records as Scott Kenneth Milsten, acquired the securities as company awards: 4,995 restricted stock units on 06/01/2024 and 10,005 performance stock units on 04/17/2024. The filing also shows recent 10b5-1 plan sales: 55,581 shares on 09/10/2025 (gross proceeds $7,479,016.63) and 15,000 shares on 09/12/2025 (gross proceeds $2,104,264.50). Total shares outstanding noted: 56,734,903.